Patients will be randomly assigned to treatment groups with equal probability of assignment to each treatment arm (allocation ratio 1:1). The randomisation schedule will be generated using validated software. The investigators will remain blinded to the randomisation schedule until after the final database is locked. The randomisation schedule will be examined only if required by an emergency. Any such break should be documented clearly.